Back to Agenda
Session 3 : Regulatory Science Strategies and Case Study for Innovative Drug Development
Session Chair(s)
Youngju Choi, PhD
Director General of Biopharmaceutical & Herbal Medicine Evaluation Department , National Institute of Food & Drug Safety (NIFDS), MFDS, Korea, Republic of
Sora Lee, MBA, MPharm, RPh
Vice President, General Manager Korea , Syneos Health Inc., Korea, Republic of
Speaker(s)
Session 3 - 1
Ohseok Kwon, PhD
Recombinant Protein Products Division, Ministry of Food and Drug Safety, Korea, Republic of
Session 3 - 2
Radha Goolabsingh
Global Regulatory Strategist, DIA, United States
Session 3 - 3
Abhi Gupta
Senior Vice President, Head of Cell & Gene Therapy, Syneos Health, United States
D. Allen Callaway, MBA, MS
Director - Global Regulatory Affairs CMC, Johnson & Johnson, United States
Have an account?